The burden of chronic inflammatory diseases and cancer is escalating across the globe, while endemic and emerging infectious diseases are overwhelming health systems in under-resourced countries.
More effective drugs, vaccines, health monitoring and community-level intervention programs are needed to safeguard human lives and community wellbeing. This Platform brings together hundreds of highly respected, cross-disciplinary experts who are passionately committed to addressing innovatively the rising health challenges in our society.
Magdalena Plebanski, Director, RMIT Biomedical Health and Innovation ECP
We will harness the multidisciplinary excellence at RMIT and work with our industry partners to address areas of medical need and deliver interventions for healthy living
Along with harnessing existing research networks and projects to respond to COVID-19, RMIT’s Enabling Capability Platforms (ECPs) launched five cross-platform initiatives in June 2020 to address various key areas for post COVID-19 recovery.
Our partnerships will pursue fundamental and applied research in ageing, developing:
We will drive understanding of how urbanisation impacts human health by researching:
We will focus on the opportunities arising from:
We will focus on:
Contact Biomedical Health and Innovation ECP:
Professor Magdalena Plebanski
Tel: +61 3 9925 7263
Tel: +61 3 9925 6606
If you're not sure how you can best work with us, our team can explain what's possible and put you in touch with the right person.
Acknowledgement of country
RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business. - Artwork created by Louisa Bloomer